Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LCTXthis companyLineage Cell Therapeutics, Inc.	$1.05	-5.96×	8.63×	26.4×	-5.09×	-251.4%	94.2%	-149.6%	-436.5%	-142.6%	-19.7%	-5.1%	0.05×	0.56×	0×	5.2×	0.0%	3	-3.44	1	C-
CELUCelularity Inc.	$0.73	-0.31×	-0.75×	1.07×	-0.81×	-1859.9%	24.4%	-230.9%	-345.4%	241.0%	-151.1%	-46.6%	-1.07×	-0.45×	-9.08×	0.15×	20.8%	3	-16.24	2	C
IPSCCentury Therapeutics, Inc.	$1.74	-9.04×	0.54×	0.79×	19.64×	85.0%	88.0%	-13.8%	-8.8%	-6.0%	-7.2%	-121.6%	0.27×	-5.3×	0×	5.97×	0.0%	1	-1.94	2	C
Peer median	—	-4.68×	-0.1×	0.93×	9.41×	-887.4%	56.2%	-122.3%	-177.1%	117.5%	-79.2%	-84.1%	-0.4×	-2.87×	-4.54×	3.06×	10.4%	2	-9.09	2	—